Literature DB >> 23725875

Inflammation in tuberculosis: interactions, imbalances and interventions.

Stefan H E Kaufmann1, Anca Dorhoi.   

Abstract

Inflammation is critical for tuberculosis (TB) pathogenesis. The nonresolving aspect of inflammation in TB is caused by sophisticated intracellular survival strategies of tubercle bacilli. TB is a continuum comprising a spectrum of lesions as a consequence of complex regulation of inflammation. Proinflammatory cytokines, including interferons, tumor necrosis factor and interleukin 1 along with microRNAs and eicosanoids form an interactive network during TB. Cross-regulation between proinflammatory mediators strongly impacts on infected cell death patterns. These processes, in concert with local concentrations of proteases, such as cathepsins, serpins and matrix-metalloproteinases, affect tissue integrity, shape the architecture of granulomas and modulate tissue repair. With inflammation networks being uncovered in TB, the relevance of several pathways for novel interventions becomes clearer.
Copyright © 2013 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2013        PMID: 23725875     DOI: 10.1016/j.coi.2013.05.005

Source DB:  PubMed          Journal:  Curr Opin Immunol        ISSN: 0952-7915            Impact factor:   7.486


  40 in total

Review 1.  Vaccination against infectious diseases: what is promising?

Authors:  Hans Wilhelm Doerr; Annemarie Berger
Journal:  Med Microbiol Immunol       Date:  2014-07-27       Impact factor: 3.402

2.  Increased risk of incident osteoporosis and osteoporotic fracture in tuberculosis patients: a population-based study in a tuberculosis-endemic area.

Authors:  Y-Y Chen; J-Y Feng; W-Y Ting; Y-F Yen; P-H Chuang; S-W Pan; V Y-F Su; W-J Su
Journal:  Osteoporos Int       Date:  2017-03-22       Impact factor: 4.507

3.  Mycobacterium marinum down-regulates miR-148a in macrophages in an EsxA-dependent manner.

Authors:  Haichong Wu; Yanqing Bao; Lin Wang; Xiujun Li; Jianjun Sun
Journal:  Int Immunopharmacol       Date:  2019-05-09       Impact factor: 4.932

4.  Early Whole Blood Transcriptional Signatures Are Associated with Severity of Lung Inflammation in Cynomolgus Macaques with Mycobacterium tuberculosis Infection.

Authors:  Hannah P Gideon; Jason A Skinner; Nicole Baldwin; JoAnne L Flynn; Philana Ling Lin
Journal:  J Immunol       Date:  2016-11-11       Impact factor: 5.422

Review 5.  Host-Directed Therapies for Tuberculosis.

Authors:  David M Tobin
Journal:  Cold Spring Harb Perspect Med       Date:  2015-05-18       Impact factor: 6.915

6.  Computational modeling predicts IL-10 control of lesion sterilization by balancing early host immunity-mediated antimicrobial responses with caseation during mycobacterium tuberculosis infection.

Authors:  Nicholas A Cilfone; Christopher B Ford; Simeone Marino; Joshua T Mattila; Hannah P Gideon; JoAnne L Flynn; Denise E Kirschner; Jennifer J Linderman
Journal:  J Immunol       Date:  2014-12-15       Impact factor: 5.422

7.  Host-directed therapy of tuberculosis based on interleukin-1 and type I interferon crosstalk.

Authors:  Katrin D Mayer-Barber; Bruno B Andrade; Sandra D Oland; Eduardo P Amaral; Daniel L Barber; Jacqueline Gonzales; Steven C Derrick; Ruiru Shi; Nathella Pavan Kumar; Wang Wei; Xing Yuan; Guolong Zhang; Ying Cai; Subash Babu; Marta Catalfamo; Andres M Salazar; Laura E Via; Clifton E Barry; Alan Sher
Journal:  Nature       Date:  2014-06-25       Impact factor: 49.962

Review 8.  Novel vaccination strategies against tuberculosis.

Authors:  Peter Andersen; Stefan H E Kaufmann
Journal:  Cold Spring Harb Perspect Med       Date:  2014-06-02       Impact factor: 6.915

Review 9.  Repurposing drugs for treatment of tuberculosis: a role for non-steroidal anti-inflammatory drugs.

Authors:  Arundhati Maitra; Sadé Bates; Monisha Shaik; Dimitrios Evangelopoulos; Ibrahim Abubakar; Timothy D McHugh; Marc Lipman; Sanjib Bhakta
Journal:  Br Med Bull       Date:  2016-05-05       Impact factor: 4.291

Review 10.  Platelet Activation and the Immune Response to Tuberculosis.

Authors:  Daniela E Kirwan; Deborah L W Chong; Jon S Friedland
Journal:  Front Immunol       Date:  2021-05-19       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.